Shanghai Pharmaceuticals Holding Co., Ltd Share Price Other OTC
Stocks
SHPMY
US81943R1005
Pharmaceuticals
OTC Markets Traded| Market Cap | 54.11B 8.07B 6.95B 6.58B 5.96B 11.19B 771B 11.25B 78.15B 30.05B 392B 30.29B 29.63B 1,239B | P/E 2026 * |
10.7x | P/E 2027 * | 10.1x |
|---|---|---|---|---|---|
| Enterprise Value | 56.82B 8.47B 7.3B 6.91B 6.26B 11.75B 809B 11.81B 82.06B 31.56B 412B 31.81B 31.11B 1,301B | EV / Sales 2026 * |
0.19x | EV / Sales 2027 * | 0.21x |
| Free-Float |
41.21% | Yield 2026 * |
2.81% | Yield 2027 * | 2.98% |
| 1 day | -3.18% |
| Manager | Title | Age | Since |
|---|---|---|---|
Ya Dong Zhou
DFI | Director of Finance/CFO | 54 | 24/06/2026 |
Yong Zhong Li
PSD | President | 56 | 28/06/2023 |
Bo Shen
DFI | Director of Finance/CFO | 53 | 04/06/2013 |
| Director | Title | Age | Since |
|---|---|---|---|
Bo Shen
BRD | Director/Board Member | 53 | 27/06/2016 |
Yong Zhong Li
BRD | Director/Board Member | 56 | 26/06/2019 |
Ming Dong
BRD | Director/Board Member | 49 | 28/06/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.18% | +4.04% | - | - | 8.07B | |
| +0.07% | -2.92% | +22.47% | +107.95% | 103B | |
| -0.61% | -5.10% | +53.85% | +161.42% | 54.56B | |
| -0.38% | -2.59% | -12.33% | +250.67% | 21.7B | |
| -0.12% | -1.99% | -10.93% | -8.74% | 8.07B | |
| -1.35% | -4.06% | -38.62% | -33.32% | 6.86B | |
| +0.59% | +0.68% | +3.49% | +31.73% | 6.82B | |
| -0.90% | -2.10% | -19.20% | -29.86% | 6.11B | |
| -10.00% | +1.12% | +354.83% | +495.04% | 4.6B | |
| +0.30% | +0.06% | -4.49% | +19.70% | 5.07B | |
| Average | -1.56% | -1.76% | +38.78% | +110.51% | 24.06B | |
| Weighted average by Cap. | -0.52% | -3.11% | +28.36% | +126.76% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 296B 44.17B 38.06B 36.04B 32.66B 61.28B 4,220B 61.59B 428B 165B 2,147B 166B 162B 6,784B | 315B 46.89B 40.4B 38.26B 34.68B 65.05B 4,480B 65.38B 454B 175B 2,279B 176B 172B 7,202B |
| Net income | 5.64B 840M 724M 685M 621M 1.17B 80.25B 1.17B 8.14B 3.13B 40.83B 3.15B 3.09B 129B | 5.8B 864M 744M 705M 639M 1.2B 82.53B 1.2B 8.37B 3.22B 41.99B 3.24B 3.17B 133B |
| Net Debt | 2.71B 404M 348M 329M 298M 560M 38.56B 563M 3.91B 1.5B 19.62B 1.52B 1.48B 62B | 12.55B 1.87B 1.61B 1.53B 1.38B 2.6B 179B 2.61B 18.13B 6.97B 90.93B 7.03B 6.87B 287B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
